Carb-X

World Anti-Microbial Resistance Congress 2018
2018-10-25 - 2018-10-26 | Rits Carlton, 1150 22nd St NW, Washington, DC, 20037, United States
At the 4th Annual World Anti-Microbial Resistance Congress, over 400 stakeholders will gather in Washington D.C. to discuss critical challenges and opportunities to advance antibiotic and diagnostics development, improve antimicrobial stewardship practice and incentivize funding and partnering to bring innovation to patients and the healthcare system in need. Discussions will be addressing 4 key areas: Antibiotic R&D, Diagnostics, Antimicrobial Stewardship, and Innovation Showcase.
Presentations by Tyler Merkeley of BARDA and Dr. Barry Eisenstein, Chair of the CARB-X Advisory Board.

BARDA Industry Day
2018-10-29 - 2018-10-30 | Grand Hyatt Washington, 1000 H St NW, Washington, DC, 20001, United States
The Biomedical Advanced Research and Development Authority (BARDA), a component of the U.S. Department of Health and Human Services Administration for Strategic Preparedness and Response (ASPR), invites you to participate in our annual conference at which you can learn about U.S. Government medical countermeasure priorities, interact with BARDA and ASPR staff, and network with public and private sector colleagues working in this space.
This year’s theme focuses on the importance of innovation and collaboration.

2018 BioInfect Conference
2018-11-08 08:00 - 17:00 (Europe/London) | Alderley Park Conference Centre, Alderly Park, Cheshire, SK10 4TG, United Kingdom
Antimicrobial resistance is an increasingly serious threat to global public health that requires action across all government sectors and society. BioInfect will look at the critical issues relating to the development of new anti-infectives and the endemic problem of resistance.

Dr. Richard Lawson, CARB-X Senior Project Manager, will be delivering the keynote address.

Lecture by Kevin Outterson: Why is a lawyer leading antibiotic R&D at CARB-X?
2018-11-12 00:30 - 13:30 (Europe/London) | Wellcome Trust, Euston Road, London, NW1, United Kingdom
Kevin Outterson is the N Neal Pike Professor of Health and Disability Law at Boston University and the Executive Director of CARB-X, the world’s largest product development partnership addressing drug-resistant bacterial infections. He will share his personal stories of how experiences, skills, passion and faith converge in the efforts to protect us all from drug-resistant bacterial infections.

All-Party Parliamentary Group on Antibiotics: How close are we to meeting the urgent need for new antibiotics?
2018-11-13 15:00 - 17:00 (Europe/London) | 1 Parliament Street, 1 Parliament Street, London, A3212,, United Kingdom
The All-Party Parliamentary Group on Antibiotics APPG-A exists to raise the profile of antibiotic resistance, the need to preserve antibiotics through education on their appropriate use including non‐human uses, the lack of new treatments for bacterial infections and to help accelerate efforts to discover, research and develop new treatments.
The British Society for Antimicrobial Chemotherapy serves as Secretariat to the APPG-A.
This meeting will focus on the work of partnership bodies like CARB-X and the Global Antibiotic Research & Development Partnership (GARDP) in relation to antibiotic development, pipeline coordination, and the legacy of the DRIVE-AB initiative.
Speakers include Kevin Outterson, Executive Director of CARB-X

GARDP Webinar: Making Safety a Part of Drug Design
2018-11-13 17:00 (Europe/Berlin) | Webinar
This webinar aims at making a presentation of a recent GARDP co-organized conference session accessible to anyone who didn’t have the chance to attend the meeting.
After the showing of the recording of her presentation “Making Safety a Part of Drug Design”, Claire Sadler will join us online for a live Q&A session. This presentation was part of the GARDP and CARB-X co-organized “Antibiotic Bootcamp for Developers: Preclinical Toxicology” at the ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance in Lisbon in September 2018.
Speaker: Claire Sadler
Moderator: Ursula Theuretzbacher
Host: François Franceschi
Please click here to register.

Max Planck Institute for Innovation and Competition Conference
2018-11-16 | Berlin, Berlin, Germany
Additional details to follow.

Presentation by Kevin Outterson, Executive Director of CARB-X.

Call to Action on Antimicrobial Resistance
2018-11-19 08:00 - 2018-11-20 17:00 (Africa/Accra) | Accra, Ghana, Accra, Ghana
Wellcome Trust is to co-host a second global conference to help drive pioneering action to stop the rise and spread of superbugs. The two-day Call to Action, taking place in Accra this November, is co-hosted with the governments of Ghana and Thailand, and the United Nations Foundation, and is organized in partnership with the Inter-Agency Coordination Group (IACG) on Antimicrobial Resistance.
Health representatives from national governments and agencies, civil society, the private sector and global philanthropies will be invited to come together at the Call to Action to focus on how to address the most critical gaps in tackling the development and spread of drug-resistant infections.
Invitation Only
Attendees include Kevin Outterson, Executive Director of CARB-X.

Call to Action Side Event: Access and stewardship plans during antibiotic research and development
2018-11-20 07:30 - 08:45 (America/New_York) | Accra, Ghana, Accra, Ghana
This event is an invitation-only side event to the 2nd Call to Action on Antimicrobial Resistance hosted by the Access to Medicine Foundation, the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) and the Global Antibiotic Research & Development Partnership (GARDP). In this session, the Access to Medicine Foundation, CARB-X and GARDP will share how they guide, support and partner with pharmaceutical companies to achieve access and stewardship goals. Presentations will be followed by an open discussion related to the role of different sectors in improving access and stewardship strategies during the R&D process.

6th annual meeting of the Boston Area Antibiotic Resistance Network
2018-12-07 08:30 - 19:00 (America/New_York) | Starr Center for Conferences, 185 Cambridge St., Boston, MA, 02114, United States
Speakers include Karen Gallant, Global Program Director of CARB-X.

CARB-X: Combating Antibiotic Resistance Globally
2019-01-15 12:00 - 13:00 (America/New_York)
With Kevin Outterson. A Boston University Alumni Association special webinar event for BU alumni, but all are welcome to join. Register online

ECRAID-Plan Kick-off meeting
2019-01-17 | Brussels, Belgium, Brussels, Belgium
The European Clinical Research Alliance on Infectious Diseases (ECRAID) focuses on two major challenges: emerging infectious diseases (EID) with epidemic or pandemic potential, caused by new or re-emerging pathogens, and antimicrobial resistance (AMR). This meeting aims to bring together the ECRAID-Plan Project Consortium, Working Group, and key stakeholders to constructively discuss ECRAID and its sustainable solutions to protect Europe, and beyond, from AMR and EID threats over the long-term. This is a closed meeting.
Kevin Outterson, Executive Director of CARB-X, will be on the stakeholder advisory panel. Keynote speakers include EU Commissioner for Research, Science and Innovation, Carlos Moedas, and Wellcome Trust Director, Jeremy Farrar.

REVIVE Webinar: Clinical development for non-developers Part 3: Antibacterial Drug Enhancer Combinations and Non-traditional Products
2019-01-29 11:00 - 12:30 (America/New_York) | WEBINAR, Webinar, Webinar, United States
On the 29th of January 2019, Ian Friedland, Sumathi Nambiar, Mair Powell, and David Shlaes will join us for a live webinar about antibacterial drug enhancer combinations and non-traditional products. Following their short presentations, the speakers will be available on the line to respond to your questions.

Hamied Foundation UK-India Antimicrobial Resistance Meeting 2019
2019-02-04 - 2019-02-05 | The Hallam Conference Centre, 44 Hallam Street, London, United Kingdom
The meeting is being organised as part of a programme of work to strengthen the research links between the UK and India with the specific aim of jointly addressing the challenge of AMR.

Webinar - NIAID Resources to Facilitate Discovery & Development of Anti-Infectives
2019-02-21 17:00 - 18:30 (Europe/Paris) | Webinar, 765 Commonwealth Avenue, Boston, MA, 02215, United States
Speakers include Ann Eakin, Senior Scientific Officer Office of Biodefense, Research Resources & Translational Research, DMID/NIAID/NIH, member of the CARB-X Joint Oversight Committee.
In this presentation, Ann Eakin (US National Institute of Allergy and Infectious Diseases, NIAID) will provide an overview of the various mechanisms of support offered by NIAID to facilitate the discovery and development of drugs, vaccines and diagnostics targeting infectious diseases. The types of support that will be discussed are grants and contracts, as well as preclinical and clinical research services that aim to reduce risk and advance product development efforts. Researchers from any country and from any type of institution (academia, industry, non-profit) are eligible to apply for nearly all types of support mechanisms offered by NIAID, irrespective of prior or current NIH funding.
Ann’s presentation will be complemented by a short presentation of Dan Pevear, Founder and Senior Vice President, Biology and Grants Development, VenatoRx Pharmaceuticals, in which he will share VenatoRx’ experience with NIAID support mechanisms.
The presentations will be followed by a Q&A session.

US FDA Regulatory Approval Process for Anti-microbials Workshhop
2019-03-06 | C-CAMP, Chausa, Bengaluru, India
Workshop hosted by the Centre for Cellular And Molecular Platforms (C-CAMP), a member of the CARB-X Accelerator Network.

The 12th Berlin Conference on Life Sciences - Novel Antimicrobials and AMR Diagnostics 2019
2019-03-14 - 2019-03-15 | Radisson Blu Hotel, Karl-Liebknecht-Strasse 3, Berlin, 10178, Germany
Speakers include Kevin Outterson, CARB-X Executive Director.
The Novel Antimicrobials and AMR Diagnostics 2019 conference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.

BSAC Spring Conference 2019
2019-03-21 - 2019-03-22 | International Convention Center, 8 Centenary Square, Birmingham, B1 2EA, United Kingdom
Global views, local problems: Innovative solutions to AMR and infection challenges.
The British Society for Antimicrobial Chemotherapy (BSAC) 2019 Spring Conference offers a state of the art overview of the infection management and antimicrobial resistance landscape. The programme includes keynote lectures, plenary and parallel sessions, debates and an opening series of spotlight presentations – offering insights into the latest in drug discovery and development, socio-economic challenges, new and emerging treatments and diagnostics and debates and challenges policies and usage of antibiotic regimens. Globally focused and locally relevant, the conference brings together key opinion leaders, researchers and clinicians from across Europe and further afield. Alongside the networking and exhibition areas, this event offers outstanding opportunities for education and engagement to all delegates.

Longitude Prize AMR Diagnostics Boston Workshop
2019-03-21 08:30 - 14:00 (America/New_York) | Boston University School of Law, 765 Commonwealth Avenue, Boston, MA, 02215, United States
Speakers include Kevin Outterson, CARB-X Executive Director.
The Longitude Prize is an international challenge prize competition that will ultimately select one point-of-care diagnostic product to receive a grand payout of 8 million British Pounds ($9.1 million). The winner will have proven that their test can significantly reduce misuse or overuse of antibiotics by creating an affordable, accurate and rapid point-of-care diagnostic test. This test must be practical to use in the North America and Europe as well as low and middle-income countries (LMICs). There are currently 83 teams competing for the Prize from 14 countries with a broad mix of entries from industry and academia. The Prize Rules can be found here.
The purpose of this workshop is to give existing competitors and those interested in competing more information regarding the Longitude Prize competition to help steer projects toward a winning configuration, hear from experts on test needs in the United Kingdom (National Health Service) and lower and middle-income contexts (LMICs), and to provide a chance for test developers to engage with Longitude judges and the Nesta Team.
The Longitude Prize is hosted and managed by the Challenge Prize Centre at Nesta, the Innovation Foundation based in London.
Please RSVP to Ruth Neale at ruth.neale@nesta.org.uk by Friday March 8, 2019 if you plan to attend the workshop.

Inaugural Bacteriophage Therapy Summit
2019-03-25 - 2019-03-27 | Revere Boston Common, 200 Stuart St., Boston, MA, 02116, United States
Speakers include Karen Gallant, CARB-X Global Project Director.
The 1st Bacteriophage Therapy Summit is the only meeting uniting large pharma, biotech companies, research institutions and technology experts to harness bacteriophage science and accelerate the clinical development of effective phage therapy. Join the leaders in phage therapy product development as they discuss the latest data-driven case studies and forge collaborations you need to unlock the full potential of bacteriophage therapeutics.
See the full agenda and speaker list here.
CARB-X subscribers qualify for an exclusive 10% discount with VIP Code 12259CARBX.

The Economist Antimicrobial Resistance Summit - Preventing an Antibiotic Apocalypse
2019-03-26 | BMA House Conference and Events Venue, Tavistock Square, Bloomsbury, London, WC1H 9JP, United Kingdom
Speakers include Kevin Outterson, CARB-X Executive Director.
Join 120+ health policy leaders, academics and other experts across the industry for a frank discussion to catalyse progress in bringing AMR under control, before it is too late. A series of expert panel discussions will dig into the topics that matter the most, using the convening power of The Economist brand to get the right people working together.

GARDP Webinar - Clinical development for non-developers Part 3: Antibacterial Drug Enhancer Combinations and Non-traditional Products
2019-03-28 17:00 - 18:30 (Europe/Paris) | Webinar
The overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks of development for various kinds of antibacterial products. In this third webinar, we will discuss the development of antibacterial drug enhancer combinations and non-traditional products.
The webinar will be held from 5:00 pm – 6:30 pm CET / 12:00 pm – 13:30 pm EDT.
The presentations will be followed by a Q&A session.

REPAIR Impact Fund is open for investment proposals...
2019-04-01
…from European life science companies until May 10. Information about how to apply can be found at here.

The REPAIR Impact Fund is now open for investment proposals from European life science companies targeting AMR. Companies are invited to submit a non-confidential proposal, which will be evaluated during the spring. Successful projects will be invited to submit more extensive confidential proposals.

The window for submissions will be open until May 10th. Additional information and the proposal template can be found here.

This investment round is the second to European companies. Companies that took part in the first investment round without obtaining funding are very welcome to take part in this new round.

Annual ECCMID Meeting
2019-04-13 - 2019-04-16 | RAI Amsterdam, Europaplein, Amsterdam, NL 1078 GZ, Netherlands
ECCMID, as the world’s premier Clinical Microbiology & Infectious Diseases event, brings together experts from many fields to present their latest findings, guidelines and experiences to an audience of over 12,000 colleagues. This year, the Programme Committee has developed a multi-faceted program incorporating keynote lectures and oral sessions, as well as interactive workshops, meet-the-expert sessions, and a wide range of symposia.

19th World Vaccine Congress
2019-04-15 | Renaissance Washington DC Downtown Hotel, 999 9th St NW, Washington, DC, 20001, United States
Speakers include Dr. Barry Eisenstein, Chair of the CARB-X Advisory Board.
For the past 18 years, the World Vaccine Congress Washington congress has evolved and grown into the leading vaccines congress globally, with: 300 speakers, 1500 attendees and hundreds of networking opportunities. This year’s congress will feature a variety of pre-congress workshops and conferences in:

Cancer Immunotherapy
Immune Profiling
Respiratory Vaccines
Emerging & Re-emerging Diseases
Clinical Trials
Vaccine Partnerships
Bioprocessing & Manufacturing
Vaccines Safety
Logistics
Veterinary Vaccines

Throughout these sessions participants will learn how cutting-edge research efforts can be integrated with pharma, biotech, academia and government to produce more and better vaccines to the market.

ICOHAR, International Conference on One Health Antimicrobial Resistance
2019-04-16 - 2019-04-18 | Jaarbeusplein, Ulrecht, Netherlands
It is generally recognized that control and prevention of antimicrobial resistance (AMR) requires a holistic One Health approach involving specialists from different sectors. In line with this concept, the 2nd ICOHAR aims to bring together representatives from all relevant sectors (e.g. public health, human and veterinary medicine, livestock production, food safety and environmental sciences) to share research and education strategies for understanding and reducing the risks of AMR at the interphase between humans, animals and the environment. The programme does not only focus on zoonotic transfer of AMR but also on the numerous AMR-related challenges shared by clinicians, clinical microbiologists, infectious disease specialists and researchers working in these sectors.
To view the program, please click here.

Annual SHEA (Soc. for Hospital Epidemiology of America) Spring meeting
2019-04-24 - 2019-04-26 | Westin Boston Waterfront, 425 Summer St, Boston, MA, 02210, United States
This conference is designed for physicians, infection preventionists, healthcare epidemiologists, infectious disease specialists, microbiologists, nurses, pharmacists, and other healthcare professionals interested in healthcare epidemiology, infection prevention, Antimicrobial Stewardship, surveillance, research methods, patient safety, environmental issues, and quality improvement.
The SHEA 2019 Program Committee combines the expertise of SHEA members who have served on SHEA meeting planning committees for many years and active leaders from the SHEA Education Committee. It also includes broad subject matter expertise in healthcare epidemiology, antibiotic stewardship, long-term care, research methods, clinical microbiology, patient safety and quality, implementation science, and a wide range of opportunities for networking and communication with peers and experts in the field.
To view the agenda, please click here.

National Academy of Sciences 155th Annual Meeting
2019-04-28 - 2019-05-01 | National Academy of Sciences, 2101 Constitution Ave., N.W., Washington, DC, United States
Advising the Nation. Advancing the Discussion. Connecting New Frontiers.
Society is facing an array of complex policy questions. The National Academies of Sciences, Engineering, and Medicine provides nonpartisan, objective guidance for decision makers on pressing issues. and marshals the energy and intellect of the nation’s critical thinkers to respond to policy challenges with science, engineering, and medicine at their core.
Through a meticulous process of information collection, evidence analysis, and deliberation, NAS studies provide blueprints for progress. By shining a spotlight on subjects and facilitating dialogue across disciplines, their work advances understanding of critical issues.
For information on live webcasts, click here.
For information on the agenda click here.
Visit the NAS website here.

37th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID)
2019-05-06 - 2019-05-11 | Ljubljana, Slovenia
The 37​th Annual Meeting of the European Society for Paediatric Infectious Diseases will feature a wide range of sessions and learning opportunities showcasing the latest research and developments in the field hosted by leading international experts. The meeting aims to bring together the most prominent researchers in the field of paediatric infectious diseases, immunology and epidemiology and to fill in the gaps between these disciplines in a relaxed, smart albeit casual atmosphere.

Live Webinar: CARB-X 2019 Funding Rounds
2019-05-16 09:00 - 10:00 (America/New_York) | Webinar, 765 Commonwealth Avenue, Boston, MA, 02215, United States
Kevin Outterson, CARB-X Executive Director, and Karen Gallant, CARB-X Global R&D Project Director, present details of CARB-X’s four new funding rounds announced April 30, 2019, and answer questions during this webinar. To attend the live webinar, please register by clicking the link below. A recording of the webinar will be available for viewing shortly after the event. The recording will be available on the CARB-X website in the Apply > What CARB-X funds section.
Please click here to register.
